Literature DB >> 12464488

Optimization of electroporation conditions for Mycobacterium avium.

S-H Lee1, M Cheung, V Irani, J D Carroll, J M Inamine, W R Howe, J N Maslow.   

Abstract

Successful transformation and subsequent genetic manipulation of Mycobacterium avium requires suitable vectors, efficient transformation systems, and reliable selectable markers. A systematic analysis of the parameters involved in the transformation of M. avium was performed to optimize DNA transfer. Factors examined included the composition of the growth medium, growth medium additives, variations in washing of the bacteria prior to electroporation, and conditions of electroporation. Of the parameters assayed, the frequency of transformation (defined as the number of transformants per 10(6) transformed bacteria) showed the greatest increase with the addition of 1.5% glycine to the M. avium culture medium and the use of higher concentrations of plasmid DNA. The addition of 0.5 M sucrose to the growth medium and wash solution yielded a modest increase in transformation frequency, but more importantly afforded greater consistency of results between different batches of cells with no decrease in transformation yields following freezing and thawing. We also confirmed that gfp could be used as a selective marker for M. avium, even as a single copy integrant, and allowed for rapid discrimination between false and true transformants. Using this protocol, we were able to transform nine of 11 clinical strains of M. avium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464488     DOI: 10.1054/tube.2002.0335

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  8 in total

1.  Genes required for intrinsic multidrug resistance in Mycobacterium avium.

Authors:  Julie S Philalay; Christine O Palermo; Kirsten A Hauge; Tige R Rustad; Gerard A Cangelosi
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis.

Authors:  Irène Caire-Brändli; Alexia Papadopoulos; Wladimir Malaga; David Marais; Stéphane Canaan; Lutz Thilo; Chantal de Chastellier
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

3.  Potent antimycobacterial activity of the pyridoxal isonicotinoyl hydrazone analog 2-pyridylcarboxaldehyde isonicotinoyl hydrazone: a lipophilic transport vehicle for isonicotinic acid hydrazide.

Authors:  Samantha Ellis; Danuta S Kalinowski; Lisa Leotta; Michael L H Huang; Peter Jelfs; Vitali Sintchenko; Des R Richardson; James A Triccas
Journal:  Mol Pharmacol       Date:  2013-11-15       Impact factor: 4.436

4.  Optimization and Comparison of Different Methods and Factors for Efficient Transformation of Brucella abortus RB51strain.

Authors:  Azam Gheibi; Hossein Khanahmad; Gholam Ali Kardar; Maryam Boshtam; Sassan Rezaie; Bahram Kazemi; Mohammad Reza Khorramizadeh
Journal:  Adv Biomed Res       Date:  2019-05-30

5.  Illegitimate recombination: an efficient method for random mutagenesis in Mycobacterium avium subsp. hominissuis.

Authors:  Faisal Asghar Khattak; Ashutosh Kumar; Elisabeth Kamal; Ralph Kunisch; Astrid Lewin
Journal:  BMC Microbiol       Date:  2012-09-11       Impact factor: 3.605

6.  Development of an electrotransformation protocol for genetic manipulation of Clostridium pasteurianum.

Authors:  Michael E Pyne; Murray Moo-Young; Duane A Chung; C Perry Chou
Journal:  Biotechnol Biofuels       Date:  2013-04-09       Impact factor: 6.040

7.  Utilization of a ts-sacB selection system for the generation of a Mycobacterium avium serovar-8 specific glycopeptidolipid allelic exchange mutant.

Authors:  Vida R Irani; Sun-Hwa Lee; Torsten M Eckstein; Julia M Inamine; John T Belisle; Joel N Maslow
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-09-30       Impact factor: 3.944

8.  Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response.

Authors:  Mahdieh Sarmadi; Azam Gheibi; Hossein Khanahmad; Mohammad Reza Khorramizadeh; Seyed Hossein Hejazi; Noushin Zahedi; Hamidreza Mianesaz; Khosrow Kashfi
Journal:  Vaccines (Basel)       Date:  2022-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.